Free Trial
NASDAQ:RNTX

Rein Therapeutics (RNTX) Stock Price, News & Analysis

Rein Therapeutics logo
$1.19 +0.06 (+5.52%)
As of 10:05 AM Eastern

About Rein Therapeutics Stock (NASDAQ:RNTX)

Key Stats

Today's Range
$1.11
$1.19
50-Day Range
$1.10
$1.88
52-Week Range
$1.04
$4.40
Volume
18,669 shs
Average Volume
50,526 shs
Market Capitalization
$27.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Receive RNTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rein Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

RNTX Stock News Headlines

Silver’s Still Under $35… For Now.
Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinking and demand surging from AI, EVs, and defense tech, this could be the most overlooked setup of 2025. Most investors haven’t caught on yet.tc pixel
See More Headlines

RNTX Stock Analysis - Frequently Asked Questions

Rein Therapeutics' stock was trading at $2.05 at the beginning of the year. Since then, RNTX shares have decreased by 41.8% and is now trading at $1.1924.

Rein Therapeutics Inc. (NASDAQ:RNTX) released its earnings results on Thursday, August, 14th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.22) by $0.06.

Top institutional shareholders of Rein Therapeutics include BIOS Capital Management LP (7.34%), Voss Capital LP (6.22%), University of Texas Texas AM Investment Management Co. (2.31%) and Cable Car Capital LP (1.82%).

Shares of RNTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/14/2025
Today
8/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RNTX
CIK
1420565
Web
N/A
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.69)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$62.88 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-141.11%
Return on Assets
-33.83%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.86
Quick Ratio
1.39

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.46 per share
Price / Cash Flow
2.57
Book Value
$0.13 per share
Price / Book
9.17

Miscellaneous

Outstanding Shares
23,310,000
Free Float
22,116,000
Market Cap
$27.79 million
Optionable
N/A
Beta
1.31
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:RNTX) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners